This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Microdosing, if you have not yet heard of it, is hotter than just any ordinary trend: Science proves THC and CBD safe, with very real benefits associated with consuming very low doses regularly, as opposed to massive doses all at once. People are microdosing psychedelics, vitamins, near everything for health purposes.
together with research collaborators at the University of Auckland , have received NZ$1.44 million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosingtrial in patients with Major Depressive Disorder (MDD). mentalhealth #help #lsd #menta … [link].
Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.
Their position as therapeutic practitioners, as well as their work in conducting the kind of clinicaltrials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (
Microdose report. Two United States Senators have sent a letter to the leadership of federal agencies asking for an update and pushing for advancement on research into psychedelics. What are the regulatory barriers to research on psychedelics? They also ask for specifics, showing that this is more than just for show.
Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. For Thornton, however, microdosing psilocybin mushrooms was a question of life or death. “I I decided to try microdosing psilocybin for depression because nothing else was working for me,” explains Thornton. “I
They write, “ At the Center for Psychedelic and Consciousness Research, researchers will focus on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. The researchers hope to create precision medicine treatments tailored to the specific needs of individual patients.
Researchers will explore whether the psychoactive effects are necessary to relieve treatment-resistant depression in adults. It’s clear that alternative treatment options are necessary to combat depression and other mental illnesses, which is where companies developing psychedelic-based treatments like Optimi Health Corp.
Vincent and the Grenadines (SVG) is looking to position itself as one of the most progressive countries on the planet for psychedelic research. . If everything works out in the production and research phase, there is a clause in the license that will allow it to be expanded to clinicaltrials. and Europe.
These natural alternatives may also be effective as part of a daily “microdosing” regiment. In recent years, cannabis has been the subject of a tremendous amount of scientific research, and in 2020 there was a record number of scientific studies published on cannabis. Meditation and mindfulness. How CBD and cannabis products can help.
Scientific accomplishments (developments, discoveries, etc.). Psychedelic Invest’s intention with this publication is to raise awareness to a broader audience, in order to further develop the psychedelics ecosystem in a positive and sustainable manner. Hamilton Morris is an American journalist, documentarian, and scientific researcher.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content